Patients with arthritic ankles that were treated nonoperatively with consecutive intra-articular injections of hyaluronic acid experienced symptomatic relief which sometimes lasted for several months.
Objective: To evaluate the safety of an intra-articular injection of non-animal stabilised hyaluronic acid (NASHA) in patients with osteoarthritis (OA) of the knee. Design and setting: Non-blind ...
As joint disorders such as osteoarthritis continue to affect millions globally, healthcare providers are turning to advanced treatments that reduce pain and improve mobility without the need for ...
To determine whether intra-articular corticosteroid injections are associated with increased knee osteoarthritis progression compared to hyaluronic acid injections which has been reported to delay OA ...
Hylans have a higher molecular weight (MW) and a longer intra-articular half-life than hyaluronic acids (HAs), and might, therefore, produce more-effective, long-term pain relief when injected into ...
Few nonsurgical options are available for reducing pain and maintaining mobility of patients with hip osteoarthritis (OA). Intra-articular injections of corticosteroids or hyaluronic acid have shown ...
The FDA classifies HA for intra-articular use as Class 3 devices. There are six HA products that have FDA PMA approval for osteoarthritis of the knee. Intra—articular HA is not currently FDA approved ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. CHICAGO — Platelet-rich plasma injections provided pain ...
Researchers comparing two injections commonly used to relieve knee pain from osteoarthritis—corticosteroid and hyaluronic acid—found that corticosteroid injections were associated with higher ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results